Movento SC

Informazioni principali

  • Nome commerciale:
  • Movento SC
  • Forma farmaceutica:
  • SC sospensione concentrata
  • Utilizzare per:
  • Piante
  • Tipo di medicina:
  • Agrochimico

Documenti

  • per i professionisti:
  • Il foglio illustrativo per questo prodotto non è al momento disponibile, é possibile inviare una richiesta al nostro Servizio Clienti ed essere avvisati nel momento in cui è disponibile sulla nostra piattaforma.


    Richiedi il foglio illustrativo per i professionisti.

Localizzazione

  • Disponibile in:
  • Movento SC
    Svizzera
  • Lingua:
  • italiano

Informazioni terapeutiche

  • Gruppo terapeutico:
  • Insetticida

Altre informazioni

Status

  • Fonte:
  • UFAG - Ufficio federale dell'agricoltura. OFAG - Office fédéral de l'agriculture. BLW - Bundesamt für Landwirtschaft.
  • Numero dell'autorizzazione:
  • W-6742
  • Ultimo aggiornamento:
  • 18-11-2018

Foglio illustrativo: composizione, posologia, indicazioni, interazioni, gravidanza, allattamento, effetti indesiderati, controindicazioni

Denominazione commerciale: Movento SC

Elenco dei prodotti fitosanitari (stato: 06.11.2018)

Categoria di prodotti:

Titolare dell'autorizzazione:

Numero federale di omologazione:

Insetticida

Bayer (Schweiz) AG

W-6742

Principio:

Tenore:

Codice di formulazione:

Principio attivo: spirotetramat 9.26 % 100 g/l

SC sospensione concentrata

Applicazioni

A

Coltura

Agente patogeno/

Efficacia

Dosaggio

Restrizioni

B Fragola

Afidi

Concentrazione: 0.075 %

Applicazione: Prima della fioritura e

dopo il raccolto.

1, 2, 3

B Serra: Fragola

Aleurodidi

Concentrazione: 0.1 %

Applicazione: Prima della fioritura e

dopo il raccolto.

1, 2, 3

B Fragola

Tarsonemide della

fragola

Concentrazione: 0.1 %

Applicazione: Prima della fioritura e

dopo il raccolto.

2, 3, 4

O Ciliegio

Mosca della

ciliegia

Concentrazione: 0.125 %

Dose: 2 l/ha

Termine d'attesa: 2 Settimane

Applicazione: Stadi 81-85 (BBCH).

3, 5, 6

O Frutta a granelli

Afide grigio - rosa

del melo

Afide sanguigno

del pero

Afide verde degli

agrumi

Concentrazione: 0.09 %

Dose: 1.44 l/ha

Termine d'attesa: 3 Settimane

Applicazione: Dopo la fioritura (BBCH

69).

1, 3, 5

O Frutta a granelli

Afide lanigero del

melo

Concentrazione: 0.125 %

Dose: 2 l/ha

Termine d'attesa: 3 Settimane

Applicazione: Dopo la fioritura (BBCH

69).

1, 3, 5

O Frutta a granelli

Afide verde del

melo

Concentrazione: 0.06 %

Dose: 0.96 l/ha

Termine d'attesa: 3 Settimane

1, 3, 5

A

Coltura

Agente patogeno/

Efficacia

Dosaggio

Restrizioni

Applicazione: Dopo la fioritura (BBCH

69).

O Frutta a granelli

Cocciniglia virgola

Cocciniglie

ostreiformi

Concentrazione: 0.125 %

Dose: 2 l/ha

Termine d'attesa: 3 Settimane

Applicazione: 1 trattamento. Dopo la

fioritura (BBCH 69).

1, 3, 5, 7

O Frutta a granelli

Cocciniglia virgola

Cocciniglie

ostreiformi

Concentrazione: 0.09 %

Dose: 1.44 l/ha

Termine d'attesa: 3 Settimane

Applicazione: Dopo la fioritura (BBCH

69). 2 trattamenti.

1, 3, 5, 7

O Frutta a nocciolo

Afidi

Concentrazione: 0.06 %

Dose: 0.96 l/ha

Termine d'attesa: 3 Settimane

Applicazione: Dopo la fioritura (BBCH

69).

1, 3, 5

O Frutta a nocciolo

Cocciniglia virgola

Cocciniglie

ostreiformi

Concentrazione: 0.09 %

Dose: 1.44 l/ha

Termine d'attesa: 3 Settimane

Applicazione: 2 trattamenti. Dopo la

fioritura (BBCH 69).

1, 3, 5, 7

O Frutta a nocciolo

Cocciniglia virgola

Cocciniglie

ostreiformi

Concentrazione: 0.125 %

Dose: 2 l/ha

Termine d'attesa: 3 Settimane

Applicazione: 1 trattamento. Dopo la

fioritura (BBCH 69).

1, 3, 5, 7

O Pero

Psille del pero

Concentrazione: 0.125 %

Dose: 2 l/ha

Termine d'attesa: 3 Settimane

Applicazione: 1 trattamento. Dopo la

fioritura (BBCH 69).

3, 5, 7

O Pero

Psille del pero

Concentrazione: 0.09 %

Dose: 1.44 l/ha

Termine d'attesa: 3 Settimane

Applicazione: Dopo la fioritura (BBCH

69). 2 trattamenti.

3, 5, 7

Pieno campo: Aglio

Pieno campo: Cipolle

Pieno campo: Scalogni

Tripidi

Dose: 0.75 l/ha

Termine d'attesa: 2 Settimane

Applicazione: a intervalli di 7 - 14

giorni.

3, 8

G Pieno campo: Baby-Leaf

Afide radicicolo

Dose: 0.75 l/ha

3, 9

A

Coltura

Agente patogeno/

Efficacia

Dosaggio

Restrizioni

(Asteraceae)

della lattuga

Termine d'attesa: 2 Settimane

Applicazione: a intervalli di 7 - 14

giorni.

G Baby-Leaf (Asteraceae)

Afidi

Dose: 0.75 l/ha

Termine d'attesa: 2 Settimane

Applicazione: a intervalli di 7 - 14

giorni.

3, 9

Baby-Leaf

(Chenopodiaceae)

Afidi

Dose: 0.75 l/ha

Termine d'attesa: 2 Settimane

Applicazione: a intervalli di 7 - 14

giorni.

3, 9

Cetrioli

Zucche con buccia

commestibile

Afidi

Aleurodidi

Concentrazione: 0.075 %

Dose: 0.75 l/ha

Termine d'attesa: 3 Giorni

Applicazione: a intervalli di 7 - 14

giorni.

3, 10

Pieno campo: Cicoria

belga

Afide radicicolo

della lattuga

Afidi

Dose: 0.75 l/ha

Termine d'attesa: 2 Settimane

Applicazione: a intervalli di 7 - 14

giorni.

3, 9

Cima di rapa

Crescione

Afidi

Dose: 0.45 l/ha

Termine d'attesa: 2 Settimane

Applicazione: a intervalli di 7 - 14

giorni.

3, 9, 11

G Fagioli con baccello

Afidi

Dose: 0.75 l/ha

Termine d'attesa: 2 Settimane

Applicazione: a intervalli di 7 - 14

giorni.

3, 9

Pieno campo: Insalate

(Asteracee)

Afide radicicolo

della lattuga

Dose: 0.75 l/ha

Termine d'attesa: 2 Settimane

Applicazione: a intervalli di 7 - 14

giorni.

3, 9

G Insalate (Asteracee)

Afidi

Dose: 0.75 l/ha

Termine d'attesa: 2 Settimane

Applicazione: a intervalli di 7 - 14

giorni.

3, 9

Serra: Melanzana

Serra: Peperone

Serra: Pomodori

Afidi

Aleurodidi

Concentrazione: 0.075 %

Dose: 0.75 - 1.5 l/ha

Termine d'attesa: 3 Giorni

Applicazione: a intervalli di 7 - 14

giorni.

3, 10

A

Coltura

Agente patogeno/

Efficacia

Dosaggio

Restrizioni

Serra: Melanzana

Serra: Pomodori

Eriofidi rugginosi

Concentrazione: 0.075 %

Dose: 0.75 - 1.5 l/ha

Termine d'attesa: 3 Giorni

Applicazione: a intervalli di 7 - 14

giorni.

3, 11, 12

G Meloni

Afidi

Dose: 0.6 l/ha

Termine d'attesa: 3 Giorni

Applicazione: a intervalli di 7 - 14

giorni.

3, 10

G Meloni

Aleurodidi

Dose: 0.75 l/ha

Termine d'attesa: 3 Giorni

Applicazione: a intervalli di 7 - 14

giorni.

3, 10

G Rucola

Afidi

Dose: 0.45 l/ha

Termine d'attesa: 1 Settimane

Applicazione: Trattamento a intervalli

di 2 settimane.

3, 11, 12

Specie di cavoli [piante

giovani]

Afidi

Aleurodidi

Dose: 0.75 l/ha

Termine d'attesa: 2 Settimane

3, 10

Pieno campo: Specie di

cavoli

Afidi

Aleurodidi

Dose: 0.75 l/ha

Termine d'attesa: 2 Settimane

3, 10

G Specie di cavoli

Azione parziale:

Cecidomia del

cavolo

Tripidi

Dose: 0.75 l/ha

Termine d'attesa: 2 Settimane

Applicazione: a intervalli di 7 - 14

giorni.

3, 9

G Spinaci

Afidi

Dose: 0.75 l/ha

Termine d'attesa: 2 Settimane

Applicazione: a intervalli di 7 - 14

giorni.

3, 9

F Luppolo

Afidi

Concentrazione: 0.05 %

Termine d'attesa: 2 Settimane

Applicazione: Dallo stadio BBCH 31.

3, 11, 13, 14

F Patate

Afidi

Dose: 0.75 l/ha

Termine d'attesa: 2 Settimane

Applicazione: Trattamento a intervalli

di 2 settimane.

1, 3

Alberi e arbusti (al di fuori

della foresta)

Afidi

Concentrazione: 0.075 %

Applicazione: Trattamento a intervalli

di 2 settimane. All'inizio dell'attacco.

3, 15

A

Coltura

Agente patogeno/

Efficacia

Dosaggio

Restrizioni

Colture da fiore e piante

verdi

Afidi

Concentrazione: 0.075 %

Applicazione: Trattamento a intervalli

di 2 settimane. All'inizio dell'attacco.

3, 15

Restrizioni e osservazioni:

Al massimo 2 trattamenti per anno e particella.

La dose indicata si riferisce allo stadio "piena fioritura fino all'inizio dell'arrossamento dei

frutticini", 4 piante/m², trattamento con una quantità standard di poltiglia di 1000 l/ha.

Durante la preparazione della poltiglia: Indossare guanti di protezione. Applicazione della

poltiglia: Indossare guanti di protezione + indumenti protettivi + un copricapo. I dispositivi di

protezione individuale possono essere sostituiti, durante l'applicazione, da dispositivi di protezione

tecnici (p.es. cabina del trattore chiusa), qualora vi sia la garanzia che offrano una protezione

analoga o superiore.

Al massimo 1 trattamento per anno e particella.

La dose indicata si riferisce a un volume di alberi di 10'000 m³/ha.

Al massimo 2 trattamenti per anno e particella. Nel caso di 1 trattamento: trattamento subito prima

dell'invaiatura ed in seguito dopo ca. 7 giorni trattare con un altro prodotto autorizzato contro la

mosca della ciliegia. Nel caso di 2 trattamenti: primo trattamento subito prima dell'invaiatura ed il

secondo dopo 10 giorni.

Un solo trattamento con la dose più elevata o due trattementi con la dose piu bassa.

Al massimo 4 trattamenti per coltura.

Al massimo 2 trattamenti per coltura.

10.Al massimo 3 trattamenti per coltura.

11.Autorizzato come uso minore secondo l'art. 35 OPF (minor use).

12.1-2 trattamenti per coltura e anno.

13.Al massimo 1 trattamento per anno.

14.Per un quantitativo di base di acqua di 3000 l/ha.

15.Al massimo 2 trattamenti per anno.

Caratterizzazione di pericolo:

Tenere fuori dalla portata dei bambini.

EUH 401 Per evitare rischi per la salute umana e per l'ambiente, seguire le istruzioni per l'uso.

H317 Può provocare una reazione allergica cutanea.

H361 Sospettato di nuocere alla fertilità o al feto.

H411 Tossico per gli organismi acquatici con effetti di lunga durata.

SP 1 Non contaminare l'acqua con il prodotto o il suo imballaggio.

Avvertenza:

Attenzione

Simboli e indicazioni di pericolo:

Identificatore chiave

GHS07

GHS08

GHS09

Simbolo

Indicazione di pericolo Attenzione pericolo

Pericoloso per la

salute

Pericoloso per l'ambiente acquatico

In caso di dubbio valgono soltanto i documenti originali dell'omologazione. La menzione di un prodotto,

principio attivo o di una ditta non rappresenta alcuna raccomandazione.

16-1-2019

Safety and efficacy of Deccox® (decoquinate) for chickens for fattening

Safety and efficacy of Deccox® (decoquinate) for chickens for fattening

Published on: Mon, 14 Jan 2019 Deccox®, containing decoquinate as the active substance, is a feed additive intended to be used for the prevention of coccidiosis in chickens for fattening at a dose range of 20–40 mg/kg complete feed. Decoquinate from Deccox® is safe for chickens for fattening at the highest applied concentration in complete feed of 40 mg/kg. No practically relevant interactions with other additives or veterinary drugs exist except with bentonite. Decoquinate does not have antibacterial a...

Europe - EFSA - European Food Safety Authority EFSA Journal

21-12-2018

TGA statement on Allergan breast implant withdrawal in Europe

TGA statement on Allergan breast implant withdrawal in Europe

Allergan has withdrawn textured breast implants in Europe

Therapeutic Goods Administration - Australia

13-12-2018

Statement from FDA Commissioner Scott Gottlieb, M.D. and Director of FDA’s Center for Drug Evaluation and Research Janet Woodcock, M.D., on efforts to modernize generic drug labels while maintaining the efficiency of generic development

Statement from FDA Commissioner Scott Gottlieb, M.D. and Director of FDA’s Center for Drug Evaluation and Research Janet Woodcock, M.D., on efforts to modernize generic drug labels while maintaining the efficiency of generic development

FDA announces withdrawal of the proposed rule, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products

FDA - U.S. Food and Drug Administration

22-11-2018

Safety and efficacy of Monteban® G100 (narasin) for ducks for fattening

Safety and efficacy of Monteban® G100 (narasin) for ducks for fattening

Published on: Wed, 21 Nov 2018 Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and efficacy of Monteban® G100 for ducks. Monteban® G100, containing narasin, is intended for the prevention of coccidiosis in ducks for fattening at a dose range of 60–70 mg/kg of complete feed. Narasin from Monteban® G100 is safe for ducks for fattening at a level of 70 mg/kg complete feed...

Europe - EFSA - European Food Safety Authority Publications

15-11-2018

Safety and efficacy of Monimax® (monensin sodium and nicarbazin) for chickens for fattening and chickens reared for laying

Safety and efficacy of Monimax® (monensin sodium and nicarbazin) for chickens for fattening and chickens reared for laying

Published on: Wed, 14 Nov 2018 The coccidiostat Monimax® (monensin sodium and nicarbazin) is considered safe for chickens for fattening and chickens reared for laying at the highest use level of 50 mg monensin and 50 mg nicarbazin/kg complete feed. This conclusion is extended to chickens reared for laying. For both active substances, the metabolic pathways in the chicken are similar to those in the turkey and rat. Nicarbazin, when ingested, is rapidly split in its two components dinitrocarbanilide (DNC)...

Europe - EFSA - European Food Safety Authority Publications

13-11-2018

FDA Publishes Design Recommendations for Residue Studies in Honey

FDA Publishes Design Recommendations for Residue Studies in Honey

FDA published draft guidance for industry #243 “Studies to Evaluate the Metabolism and Residue Kinetics of Veterinary Drugs in Food-Producing Species: Study Design Recommendations for Residue Studies in Honey for Establishing MRLs and Withdrawal Periods.”

FDA - U.S. Food and Drug Administration

5-11-2018

Products containing metam-sodium: ANSES announces the withdrawal of marketing authorisations

Products containing metam-sodium: ANSES announces the withdrawal of marketing authorisations

Plant protection products containing metam-sodium are used in market gardening and horticulture to disinfect the soil. Following the substance's approval at European level, ANSES reassessed the dossiers and notified the industrial companies concerned of its intention to withdraw all marketing authorisations for metam-sodium products. ANSES is also taking this opportunity to reiterate the importance of phytopharmacovigilance and the requirement for professionals to report any adverse effects on humans or ...

France - Agence Nationale du Médicament Vétérinaire

21-9-2018

Scientific guideline:  Guideline on determination of withdrawal periods for edible tissues - Revision 1, adopted

Scientific guideline: Guideline on determination of withdrawal periods for edible tissues - Revision 1, adopted

This document provides a standard approach to be used across the European Union in the analysis of residue depletion data for the purpose of establishing withdrawal periods for edible tissues. Emphasis has been put on a statistical approach. As the method of first choice, a linear regression technique is recommended. A computerised version of the method described is available: Updated application software: withdrawal time calculation for tissues. Read together with the explanatory note on updated applica...

Europe - EFSA - European Food Safety Authority EFSA Journal

31-8-2018

Alcon Announces Voluntary Global Market Withdrawal of CyPass Micro-Stent for Surgical Glaucoma

Alcon Announces Voluntary Global Market Withdrawal of CyPass Micro-Stent for Surgical Glaucoma

Reflecting its uncompromising commitment to patient safety, Alcon today announced an immediate, voluntary market withdrawal of the CyPass Micro-Stent from the global market. In addition, Alcon advises surgeons to immediately cease further implantation with the CyPass Micro-Stent and to return any unused devices to Alcon. This decision and corresponding recommendation is based on an analysis of five-year post-surgery data from the COMPASS-XT long-term safety study. The US Food and Drug Administration (FD...

FDA - U.S. Food and Drug Administration

21-7-2018

Allergy Alert for Undeclared Milk in Food Lion Brand Dill Pickle Flavored Potato Chips

Allergy Alert for Undeclared Milk in Food Lion Brand Dill Pickle Flavored Potato Chips

Shearer’s Foods, LLC of Massillon, OH is recalling Food Lion brand 7.75 ounce packages of Dill Pickle Flavored Potato Chips because they may contain undeclared milk. People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they consume this product. The recalled Dill Pickle Flavored Potato Chips were distributed to Food Lion stores in NC, SC, GA, PA, KY, VA, TN, DE, MD, and WV between Dec 1st, 2017 and July 19, 2018.

FDA - U.S. Food and Drug Administration

16-5-2018

FDA approves the first non-opioid treatment for management of opioid withdrawal symptoms in adults

FDA approves the first non-opioid treatment for management of opioid withdrawal symptoms in adults

FDA approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults.

FDA - U.S. Food and Drug Administration

1-8-2017

Withdrawal of one more batch of counterfeit packs of the schizophrenia medicine Xeplion 150 mg

Withdrawal of one more batch of counterfeit packs of the schizophrenia medicine Xeplion 150 mg

German and Danish parallel importers and the Danish Medicines Agency are now withdrawing the fourth batch of Xeplion 150 mg from wholesale distributors, hospitals and pharmacies, because the batch contains counterfeit packs.

Danish Medicines Agency

6-4-2017

More batches of EpiPen® are withdrawn

More batches of EpiPen® are withdrawn

MEDA has decided to withdraw four more batches of EpiPen®. The withdrawal concerns two batches of EpiPen® 300 micrograms/dose and two batches of EpiPen® Jr 150 micrograms/dose. The latter is used for acute hypersensitivity reactions in children. The reason for the withdrawal is that there is a risk that the auto-injector does not work.

Danish Medicines Agency

17-3-2017

Withdrawal of a batch of EpiPen® 300 micrograms

Withdrawal of a batch of EpiPen® 300 micrograms

MEDA recalls a batch of the adrenaline product EpiPen® 300 micrograms/dose, which is used for sudden allergic reactions. There is a risk that the auto-injector does not work. The withdrawal concerns product number 578818 with batch number: 5FA665B and expiry date 03/2017.

Danish Medicines Agency

15-1-2019

Topotecan Actavis (Actavis Group PTC ehf.)

Topotecan Actavis (Actavis Group PTC ehf.)

Topotecan Actavis (Active substance: topotecan) - Withdrawal - Commission Decision (2019)207 of Tue, 15 Jan 2019

Europe -DG Health and Food Safety

19-12-2018

Macugen (PharmaSwiss CeskA republika s.r.o.)

Macugen (PharmaSwiss CeskA republika s.r.o.)

Macugen (Active substance: pegaptanib sodium) - Withdrawal - Commission Decision (2018)9064 of Wed, 19 Dec 2018

Europe -DG Health and Food Safety

14-12-2018


Withdrawn application: Fyzoclad, adalimumab, Date of withdrawal: 05/12/2018, Initial authorisation

Withdrawn application: Fyzoclad, adalimumab, Date of withdrawal: 05/12/2018, Initial authorisation

Withdrawn application: Fyzoclad, adalimumab, Date of withdrawal: 05/12/2018, Initial authorisation

Europe - EMA - European Medicines Agency

14-12-2018


Withdrawn application: Canakinumab Novartis, canakinumab, Date of withdrawal: 04/12/2018, Initial authorisation

Withdrawn application: Canakinumab Novartis, canakinumab, Date of withdrawal: 04/12/2018, Initial authorisation

Withdrawn application: Canakinumab Novartis, canakinumab, Date of withdrawal: 04/12/2018, Initial authorisation

Europe - EMA - European Medicines Agency

11-12-2018


Withdrawn application: Opdivo, nivolumab, Date of withdrawal: 27/06/2018, Post-authorisation

Withdrawn application: Opdivo, nivolumab, Date of withdrawal: 27/06/2018, Post-authorisation

Withdrawn application: Opdivo, nivolumab, Date of withdrawal: 27/06/2018, Post-authorisation

Europe - EMA - European Medicines Agency

10-12-2018

Ivabradine JensonR (JensonR+ Limited)

Ivabradine JensonR (JensonR+ Limited)

Ivabradine JensonR (Active substance: ivabradine) - Centralised - Withdrawal - Commission Decision (2018)8623 of Mon, 10 Dec 2018

Europe -DG Health and Food Safety

3-12-2018


Withdrawn application: Zydax, glucuronoxylan sulfate sodium, Date of withdrawal: 03/12/2018, Initial authorisation

Withdrawn application: Zydax, glucuronoxylan sulfate sodium, Date of withdrawal: 03/12/2018, Initial authorisation

Withdrawn application: Zydax, glucuronoxylan sulfate sodium, Date of withdrawal: 03/12/2018, Initial authorisation

Europe - EMA - European Medicines Agency

26-11-2018


Withdrawn application: HopGuard Gold, purified semi-solid extract from Humulus lupulus L. containing approximately 48% of beta acids as potassium salts, Date of withdrawal: 12/04/2018, Initial authorisation

Withdrawn application: HopGuard Gold, purified semi-solid extract from Humulus lupulus L. containing approximately 48% of beta acids as potassium salts, Date of withdrawal: 12/04/2018, Initial authorisation

Withdrawn application: HopGuard Gold, purified semi-solid extract from Humulus lupulus L. containing approximately 48% of beta acids as potassium salts, Date of withdrawal: 12/04/2018, Initial authorisation

Europe - EMA - European Medicines Agency

1-11-2018

Taxespira (Hospira UK Limited)

Taxespira (Hospira UK Limited)

Taxespira (Active substance: docetaxel) - Centralised - Withdrawal - Commission Decision (2018)7368 of Thu, 01 Nov 2018

Europe -DG Health and Food Safety

1-10-2018

IONSYS (Incline Therapeutics Europe Ltd)

IONSYS (Incline Therapeutics Europe Ltd)

IONSYS (Active substance: fentanyl) - Centralised - Withdrawal - Commission Decision (2018)6412 of Mon, 01 Oct 2018

Europe -DG Health and Food Safety

11-9-2018

 Focus group meeting  on dose optimisation of established veterinary antibiotics in the context of summary of product characteristics harmonisation, European Medicines Agency, London, UK, From: 12-Oct-2018, To: 12-Oct-2018

Focus group meeting on dose optimisation of established veterinary antibiotics in the context of summary of product characteristics harmonisation, European Medicines Agency, London, UK, From: 12-Oct-2018, To: 12-Oct-2018

This meeting will allow a direct exchange of views between the Agency’s working party and stakeholders on its draft reflection paper on dose optimisation of established veterinary antibiotics in the context of summary of product characteristics (SPC) harmonisation (EMA/CVMP/849775/2017). It complements the public consultation on this reflection paper ending on 31 January 2019. The reflection paper follows considerations in the report on a pilot project that aimed to develop and test non-experimental appr...

Europe - EMA - European Medicines Agency

22-8-2018

Gripovac 3 (Merial)

Gripovac 3 (Merial)

Gripovac 3 (Active substance: Not available) - Centralised - Withdrawal - Commission Decision (2018)5633 of Wed, 22 Aug 2018

Europe -DG Health and Food Safety

7-8-2018

Intanza (Sanofi Pasteur Europe)

Intanza (Sanofi Pasteur Europe)

Intanza (Active substance: Influenza Vaccine (split virion, inactivated)) - Centralised - Withdrawal - Commission Decision (2018)5426 of Tue, 07 Aug 2018

Europe -DG Health and Food Safety

23-7-2018

Trobalt (Glaxo Group Ltd)

Trobalt (Glaxo Group Ltd)

Trobalt (Active substance: retigabine) - Centralised - Withdrawal - Commission Decision (2018)4887 of Mon, 23 Jul 2018

Europe -DG Health and Food Safety

16-7-2018

If you are misusing an #opioid just to keep from getting sick from #withdrawal symptoms, it’s time to break the cycle of dependence. Read our “Finding Quality Treatment for Substance Use Disorders” for hotline and provider information.  http://bit.ly/2EIJ

If you are misusing an #opioid just to keep from getting sick from #withdrawal symptoms, it’s time to break the cycle of dependence. Read our “Finding Quality Treatment for Substance Use Disorders” for hotline and provider information. http://bit.ly/2EIJ

If you are misusing an #opioid just to keep from getting sick from #withdrawal symptoms, it’s time to break the cycle of dependence. Read our “Finding Quality Treatment for Substance Use Disorders” for hotline and provider information. http://bit.ly/2EIJb9l  #MondayMotivation

FDA - U.S. Food and Drug Administration

11-7-2018

Ariclaim (Eli Lilly Nederland B.V.)

Ariclaim (Eli Lilly Nederland B.V.)

Ariclaim (Active substance: duloxetine hydrochloride) - Centralised - Withdrawal - Commission Decision (2018)4515 of Wed, 11 Jul 2018

Europe -DG Health and Food Safety

10-7-2018

DepoCyte (Pacira Limited)

DepoCyte (Pacira Limited)

DepoCyte (Active substance: Cytarabine) - Centralised - Withdrawal - Commission Decision (2018)4490 of Tue, 10 Jul 2018

Europe -DG Health and Food Safety

3-7-2018

Victrelis (Merck Sharp and Dohme Limited)

Victrelis (Merck Sharp and Dohme Limited)

Victrelis (Active substance: boceprevir) - Centralised - Withdrawal - Commission Decision (2018)4244 of Tue, 03 Jul 2018

Europe -DG Health and Food Safety

25-6-2018

Angiox (The Medicines Company UK Ltd)

Angiox (The Medicines Company UK Ltd)

Angiox (Active substance: Bivalirudin) - Centralised - Withdrawal - Commission Decision (2018)4022 of Mon, 25 Jun 2018

Europe -DG Health and Food Safety

19-6-2018

SOLYMBIC (Amgen Europe B.V.)

SOLYMBIC (Amgen Europe B.V.)

SOLYMBIC (Active substance: adalimumab) - Centralised - Withdrawal - Commission Decision (2018)3913 of Tue, 19 Jun 2018

Europe -DG Health and Food Safety

1-6-2018

BTVPUR AlSap 2-4 (Merial)

BTVPUR AlSap 2-4 (Merial)

BTVPUR AlSap 2-4 (Active substance: Bluetongue Virus Serotype 2 antigen - Bluetongue Virus Serotype 4 antigen) - Withdrawal (sunset clause) - No Commission Decision

Europe -DG Health and Food Safety

29-5-2018

Meloxivet (Eli Lilly and Company Limited)

Meloxivet (Eli Lilly and Company Limited)

Meloxivet (Active substance: Meloxicam) - Centralised - Withdrawal - Commission Decision (2018)3408 of Tue, 29 May 2018

Europe -DG Health and Food Safety

16-5-2018

BTVPUR AlSap 8 (Merial)

BTVPUR AlSap 8 (Merial)

BTVPUR AlSap 8 (Active substance: Bluetongue virus Serotype 8 Antigen) - Centralised - Withdrawal - Commission Decision (2018)3018 of Wed, 16 May 2018

Europe -DG Health and Food Safety

16-5-2018

BTVPUR AlSap 1 (Merial)

BTVPUR AlSap 1 (Merial)

BTVPUR AlSap 1 (Active substance: Bluetongue Virus Serotype 1 antigen) - Centralised - Withdrawal - Commission Decision (2018)3017 of Wed, 16 May 2018

Europe -DG Health and Food Safety

15-5-2018

Imatinib Teva B.V. (Teva B.V.)

Imatinib Teva B.V. (Teva B.V.)

Imatinib Teva B.V. (Active substance: imatinib) - Centralised - Withdrawal - Commission Decision (2018)3008 of Tue, 15 May 2018

Europe -DG Health and Food Safety

30-4-2018

CERTIFECT (Merial)

CERTIFECT (Merial)

CERTIFECT (Active substance: (S)-Methoprene, Fipronil, Amitraz) - Withdrawal - Commission Decision (2018)2687 of Mon, 30 Apr 2018

Europe -DG Health and Food Safety